Pitofsky Jason
SEC CIK 2009236 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals | VP Ctrl | 5,376 | — | $2.39M | 11 | 2024-04-04 | 2026-02-09 |
Most active insiders at REGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | POON CHRISTINE A | Dir | — | $4.25M |
| 2 | McCourt Marion | EVP Commercial | — | $2.00M |
| 3 | Zoghbi Huda Y | Dir | — | $1.92M |
| 4 | Pitofsky Jason | VP Ctrl | — | $1.87M |
| 5 | Bassler Bonnie L | Dir | — | $1.77M |
| 6 | Guarini Kathryn | Dir | — | $660.0K |
| 7 | RYAN ARTHUR F | Dir | — | $434.7K |
| 8 | MURPHY ANDREW J | EVP Research | — | — |
| 9 | Fenimore Christopher R. | EVP Fin CFO | — | — |
| 10 | Schenkein David P | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-11 | 2026-02-09 | REGN | Regeneron Pharmaceuticals | Pitofsky Jason | SVP Ctrl | S - Sale+OE | $778.52 | -2,036 | 5,376 | -27% | -$1.59M |
| D | 2026-02-11 | 2026-02-09 | REGN | Regeneron Pharmaceuticals | Pitofsky Jason | SVP Ctrl | M - OptEx | $492.00 | +1,000 | 6,308 | +19% | +$492.0K |
| D | 2025-12-09 | 2025-12-08 | REGN | Regeneron Pharmaceuticals | Pitofsky Jason | VP Ctrl | F - Tax | $712.94 | -989 | 5,308 | -16% | -$705.1K |
| D | 2025-12-09 | 2025-12-05 | REGN | Regeneron Pharmaceuticals | Pitofsky Jason | VP Ctrl | A - Grant | $0.00 | +2,064 | 6,297 | +49% | $0 |
| 2025-11-10 | 2025-11-07 | REGN | Regeneron Pharmaceuticals | Pitofsky Jason | VP Ctrl | S - Sale | $651.43 | -431 | 4,233 | -9% | -$280.8K | |
| 2024-12-18 | 2024-12-16 | REGN | Regeneron Pharmaceuticals | Pitofsky Jason | VP Ctrl | F - Tax | $730.81 | -298 | 4,664 | -6% | -$217.8K | |
| DMI | 2024-12-10 | 2024-04-04+ | REGN | Regeneron Pharmaceuticals | Pitofsky Jason | VP Ctrl | G - Gift | $0.00 | +179 | 89 | New | $0 |
| D | 2024-12-10 | 2024-12-09 | REGN | Regeneron Pharmaceuticals | Pitofsky Jason | VP Ctrl | F - Tax | $787.00 | -149 | 4,962 | -3% | -$117.3K |
| D | 2024-12-10 | 2024-12-06 | REGN | Regeneron Pharmaceuticals | Pitofsky Jason | VP Ctrl | A - Grant | $0.00 | +907 | 5,111 | +22% | $0 |
| D | 2024-08-07 | 2024-08-07 | REGN | Regeneron Pharmaceuticals | Pitofsky Jason | VP Ctrl | S - Sale+OE | $1,070.00 | -487 | 4,204 | -10% | -$521.1K |
| D | 2024-08-07 | 2024-08-07 | REGN | Regeneron Pharmaceuticals | Pitofsky Jason | VP Ctrl | M - OptEx | $372.46 | +487 | 4,691 | +12% | +$181.4K |
Purchase Sale Sale after option exercise All abbreviations